Author:
Opheim Arild,Benth Jūratė Šaltytė,Solli Kristin Klemmetsby,Kloster Pia S.,Fadnes Lars Thore,Kunøe Nikolaj,Gaulen Zhanna,Tanum Lars
Subject
Pharmacology (medical),General Medicine
Reference25 articles.
1. Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose–effects and time-course;Bigelow;Drug Alcohol Depend.,2012
2. ‘Not at all what I had expected’: Discontinuing treatment with extended-release naltrexone (XR-NTX): A qualitative study;Brenna,2021
3. Drop-out from addiction treatment: A systematic review of risk factors;Brorson;Clin. Psychol. Rev.,2013
4. Transition of patients with opioid use disorder from Buprenorphine to extended-release naltrexone: a randomized clinical trial assessing two transition regimens;Comer,2020
5. Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial;Comer;Arch. Gen. Psychiatry,2006